MCID: FTL001
MIFTS: 50

Fetal Alcohol Syndrome malady

Categories: Fetal diseases, Rare diseases, Neuronal diseases

Aliases & Classifications for Fetal Alcohol Syndrome

About this section
Sources:
10Disease Ontology, 47Novoseek, 12DISEASES, 51Orphanet, 65UMLS, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 27ICD10
See all MalaCards sources

Aliases & Descriptions for Fetal Alcohol Syndrome:

Name: Fetal Alcohol Syndrome 10 47 12 51 65
Fetal Alcohol Spectrum Disorders 51 65
Fetus or Newborn Affected by Alcohol Transmitted Via Placenta or Breast Milk 65
Alcohol-Related Neurodevelopmental Disorder 51
Alcohol Related Neurodevelopmental Disorder 65
Alcohol-Related Birth Defects 51
 
Alcohol Related Birth Defect 65
Arnd 51
Arbd 51
Fasd 51
Fas 51

Characteristics:

Orphanet epidemiological data:

51
fetal alcohol syndrome:
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe),1-9/100000 (Austria),1-9/100000 (Belgium),1-5/10000 (Germany),1-9/100000 (Hungary),1-9/100000 (Ireland),1-9/100000 (Italy),1-9/100000 (Norway),1-5/10000 (Switzerland),1-9/100000 (United Kingdom),1-5/10000 (France),1-9/1000000 (Poland),1-9/100000 (Spain),6-9/10000 (Ukraine); Age of onset: Antenatal,Neonatal; Age of death: any age

Classifications:



External Ids:

Disease Ontology10 DOID:0050665
Orphanet51 1915
ICD10 via Orphanet28 Q86.0
MESH via Orphanet37 D005310
UMLS via Orphanet66 C0015923
ICD1027 Q86.0
UMLS65 C0015923, C1542327, C3146244 C0814154, C2985290, more

Summaries for Fetal Alcohol Syndrome

About this section
Disease Ontology:10 A fetal alcohol spectrum disorder that results in severe mental and physical defects which can develop in a child when the mother drinks alcohol during pregnancy. The presenting features include craniofacial dysmorphology (microcephaly, smooth philtrum, thin upper lip, small eye openings), pre- and postnatal growth deficiency, and central nervous system dysfunction.

MalaCards based summary: Fetal Alcohol Syndrome, also known as fetal alcohol spectrum disorders, is related to partial fetal alcohol syndrome and alcohol-related neurodevelopmental disorder, and has symptoms including microcephaly, narrow face and telecanthus. An important gene associated with Fetal Alcohol Syndrome is ADH1B (Alcohol Dehydrogenase 1B (Class I), Beta Polypeptide), and among its related pathways are Hypothetical Network for Drug Addiction and Nicotine addiction. Affiliated tissues include breast, eye and placenta, and related mouse phenotypes are behavior/neurological and growth/size/body region.

Related Diseases for Fetal Alcohol Syndrome

About this section

Diseases in the Fetal Alcohol Syndrome family:

Fetal Alcohol Spectrum Disorder

Diseases related to Fetal Alcohol Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 385)
idRelated DiseaseScoreTop Affiliating Genes
1partial fetal alcohol syndrome29.6ADH1B, ADH7, ADNP, AKR1A1, CHRM3, GFAP
2alcohol-related neurodevelopmental disorder12.8
3fas-related autoimmune lymphoproliferative syndrome12.5
4retinoblastoma fa - friedreich ataxia12.3
5autoimmune lymphoproliferative syndrome12.3
6fetal alcohol spectrum disorder11.9
7alcohol-related birth defect11.4
8rheumatoid arthritis10.4
9arthritis10.4
10hepatitis10.4
11familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement10.3ADH1B, AKR1A1
12lymphoma10.3
13swallowing disorders10.3GFAP, VIP
14birdshot chorioretinopathy10.3GFAP, VIP
15leukemia10.3
16cardiomyopathy10.3
17communicating hydrocephalus10.2GFAP, VIP
18prostatitis10.2
19cerebritis10.2
20hiv-110.2
21pancreatitis10.2
22neuronitis10.2
23lupus erythematosus10.2
24glioma10.2
25substance abuse10.2GFAP, PVALB
26schizophrenia10.1
27systemic lupus erythematosus10.1
28breast cancer10.1
29gastric cancer10.1
30dermatomyositis10.1
31esophagitis10.1
32temporal arteritis10.1
33amenorrhea10.1
34hepatitis c10.1
35melanoma10.1
36ovarian cancer10.1
37cervicitis10.1
38adenocarcinoma10.1
39retinitis10.1
40plasmacytoma10.1
41myopathy10.1
42t-cell leukemia10.1
43thyroiditis10.1
44vasculitis10.1
45whiplash10.1
46endotheliitis10.1
47candidiasis10.1ADH1B, GRIN2B, PVALB
48gastrointestinal stromal tumor10.0
49neuroblastoma10.0
50prostate cancer10.0

Graphical network of the top 20 diseases related to Fetal Alcohol Syndrome:



Diseases related to fetal alcohol syndrome

Symptoms for Fetal Alcohol Syndrome

About this section

Symptoms:

 51 (show all 31)
  • microcephaly
  • narrow face
  • telecanthus/canthal dystopy
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • psychic/behavioural troubles
  • short stature/dwarfism/nanism
  • intrauterine growth retardation
  • antenatal exposure : alcohol
  • narrow forehead
  • micrognathia/retrognathia/micrognathism/retrognathism
  • anophthalmos/anophthalmia/microphthalmos/microphthalmia
  • strabismus/squint
  • ptosis
  • epicanthic folds
  • short/small nose
  • anteverted nares/nostrils
  • thin/retracted lips
  • philtrum flat/large/featureless/absent cupidon bows
  • lateral cleft lip/gingival cleft/paramedian nasal cleft
  • complete/partial microdontia
  • low set ears/posteriorly rotated ears
  • vertebral segmentation anomaly/hemivertebrae
  • abnormal dermatoglyphics
  • atrial septal defect/interauricular communication
  • visceral angiomatosis (excluding skin)
  • restricted joint mobility/joint stiffness/ankylosis
  • immunodeficiency/increased susceptibility to infections/recurrent infections
  • cleft palate without cleft lip/submucosal cleft palate/bifid uvula
  • hirsutism/hypertrichosis/increased body hair
  • diaphragmatic hernia/defect/agenesis
  • stillbirth/neonatal death

HPO human phenotypes related to Fetal Alcohol Syndrome:

(show all 29)
id Description Frequency HPO Source Accession
1 microcephaly hallmark (90%) HP:0000252
2 narrow face hallmark (90%) HP:0000275
3 telecanthus hallmark (90%) HP:0000506
4 behavioral abnormality hallmark (90%) HP:0000708
5 intrauterine growth retardation hallmark (90%) HP:0001511
6 short stature hallmark (90%) HP:0004322
7 cognitive impairment hallmark (90%) HP:0100543
8 thin vermilion border typical (50%) HP:0000233
9 epicanthus typical (50%) HP:0000286
10 abnormality of the philtrum typical (50%) HP:0000288
11 narrow forehead typical (50%) HP:0000341
12 micrognathia typical (50%) HP:0000347
13 low-set, posteriorly rotated ears typical (50%) HP:0000368
14 anteverted nares typical (50%) HP:0000463
15 strabismus typical (50%) HP:0000486
16 ptosis typical (50%) HP:0000508
17 microdontia typical (50%) HP:0000691
18 limitation of joint mobility typical (50%) HP:0001376
19 atria septal defect typical (50%) HP:0001631
20 short nose typical (50%) HP:0003196
21 vertebral segmentation defect typical (50%) HP:0003422
22 abnormal dermatoglyphics typical (50%) HP:0007477
23 aplasia/hypoplasia affecting the eye typical (50%) HP:0008056
24 abnormality of immune system physiology typical (50%) HP:0010978
25 non-midline cleft lip typical (50%) HP:0100335
26 visceral angiomatosis typical (50%) HP:0100761
27 cleft palate occasional (7.5%) HP:0000175
28 congenital diaphragmatic hernia occasional (7.5%) HP:0000776
29 hypertrichosis occasional (7.5%) HP:0000998

Drugs & Therapeutics for Fetal Alcohol Syndrome

About this section

Drugs for Fetal Alcohol Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Phase 3, Phase 2, Phase 1, Phase 0
2
Epigallocatechin gallatePhase 2, Phase 356989-51-565064
Synonyms:
(-)-Epigallocatechin gallat
(-)-Epigallocatechin gallate
(-)-Epigallocatechin-3-O-gallate
(-)-Epigallocatechol gallate
(-)-Epigallocatehin gallate
Catechin deriv.
 
EGCG
Epigallocatcchin Gallate
Epigallocate
Epigallocatechin 3-gallate
Epigallocatechin Gallate
Epigallocic acid
Galloyl-L-epigallocatechol
Tea catechin
3Neuroprotective AgentsPhase 2, Phase 31376
4AntioxidantsPhase 2, Phase 32442
5Adrenergic AgentsPhase 34204
6Protective AgentsPhase 2, Phase 35651
7Neurotransmitter AgentsPhase 314795
8Atomoxetine HydrochloridePhase 3160
9Neurotransmitter Uptake InhibitorsPhase 32857
10Epigallocatechinexperimental, NutraceuticalPhase 2, Phase 3519882981
11
Cholineapproved, nutraceuticalPhase 2, Phase 113062-49-7305
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
2-Hydroxy-N,N,N-trimethylethanaminium
Bilineurine
Biocolina
Biocoline
Choline
Choline cation
 
Choline ion
Cholinum
Hepacholine
Hormocline
Lipotril
N,N,N-Trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-trimethylethanol-ammonium
N-trimethylethanolamine
Neocolina
Paresan
trimethylethanolamine
12
GlycerolexperimentalPhase 219156-81-5753
Synonyms:
1,2,3-Trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerine
Glyceritol
Glycerol
 
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
13Anti-Infective Agents, LocalPhase 2, Phase 0984
14Central Nervous System DepressantsPhase 2, Phase 010016
15Anti-Infective AgentsPhase 2, Phase 017220
16Gastrointestinal AgentsPhase 2, Phase 16401
17AntimetabolitesPhase 2, Phase 19454
18Hypolipidemic AgentsPhase 2, Phase 12228
19Nootropic AgentsPhase 2, Phase 1604
20
Nicotineapproved97354-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(+-)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(R,S)-nicotine
(RS)-nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(┬▒)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
American Fare Nicotine Transdermal System
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Careone Nicotine Transdermal System Step 1
Careone Nicotine Transdermal System Step 2
Careone Nicotine Transdermal System Step 3
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Equaline Nicotine Transdermal System STEP 1
Exchange Select Nicotine Transdermal System STEP 3
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
Habitrol Patch Nicotine Transdermal System, Step 1
Habitrol Patch Nicotine Transdermal System, Step 2
Habitrol Patch Nicotine Transdermal System, Step 3
Healthmart Nicotine Transdermal System STEP 1
Healthmart Nicotine Transdermal System STEP 2
Healthmart Nicotine Transdermal System STEP 3
Kroger Nicotine Transdermal System STEP 1
Kroger Nicotine Transdermal System STEP 2
Kroger Nicotine Transdermal System STEP 3
L(-)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
L-Nicotine
LS-202
Leader Nicotine
Leader Nicotine Transdermal System STEP 1
Leader Nicotine Transdermal System STEP 2
Leader Nicotine Transdermal System STEP 3
MLS001055457
 
MLS001335905
Mach-Nic
Meijer Nicotine Transdermal System STEP 2
Meijer Nicotine Transdermal System Step 1
Meijer Nicotine Transdermal System Step 3
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm CQ
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine TRANSDERMAL SYSTEM
Nicotine Transdermal System PATCH KIT
Nicotine Transdermal System STEP 1
Nicotine Transdermal System STEP 2
Nicotine Transdermal System STEP 3
Nicotine Transdermal System Step 1
Nicotine Transdermal System Step 2
Nicotine Transdermal System Step 3
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotine transdermal system
Nicotrol
Nicotrol (professional Sample)
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
Rite Aid Nicotine Transdermal System Step 1
Rite Aid Nicotine Transdermal System Step 2
Rite Aid Nicotine Transdermal System Step 3
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Safeway Nicotine Transdermal System STEP 1
Safeway Nicotine Transdermal System STEP 2
Safeway Nicotine Transdermal System STEP 3
Smart Sense Nicotine
Sunmark Nicotine
Sunmark Nicotine Transdermal System STEP 1
Sunmark Nicotine Transdermal System STEP 2
Sunmark Nicotine Transdermal System STEP 3
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch

Interventional clinical trials:

(show all 29)
idNameStatusNCT IDPhase
1Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHDRecruitingNCT00418262Phase 3
2Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) ChildrenRecruitingNCT02558933Phase 2, Phase 3
3Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHDActive, not recruitingNCT00417794Phase 3
4Choline Supplementation in Children With Fetal Alcohol Spectrum DisordersCompletedNCT01911299Phase 2
5Fetal Alcohol Syndrome/ARND Research ConsortionCompletedNCT00164554Phase 1, Phase 2
6Fetal Alcohol Syndrome: Socio-Cognitive HabilitationCompletedNCT00164229Phase 1, Phase 2
7Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)CompletedNCT00164346Phase 1, Phase 2
8A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)CompletedNCT00219336Phase 2
9Postnatal Choline Supplementation in Children With Prenatal Alcohol ExposureCompletedNCT01149538Phase 1, Phase 2
10Project CHOICES Efficacy StudyCompletedNCT00153478Phase 2
11Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)Active, not recruitingNCT00996528Phase 2
12Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum DisordersNot yet recruitingNCT02735473Phase 2
13Development of Education Materials for Prevention of FAS in RussiaCompletedNCT01971398
14Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic InterventionCompletedNCT02457676
15Preventing FAS/ARND in Russian ChildrenCompletedNCT01961050
16Expansion to Interdisciplinary HIV Prevention in WomenCompletedNCT01994603
17Fetal Alcohol Damage Prevention StudyCompletedNCT00696085
18Healthy Moms Alcohol InterventionCompletedNCT00244062
19Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot StudyCompletedNCT00324909
20Reducing Alcohol Exposed Pregnancy Risk: EARLY Randomized Controlled TrialCompletedNCT01446653
21Comprehensive Program for Youth Mental HealthCompletedNCT02169960
22Parenting Training for Children With FASDRecruitingNCT02210455
23Contraception and Alcohol Risk Reduction Internet Intervention Randomized TrialRecruitingNCT02128880
24Evaluating the Effectiveness of an Attachment-Focused Intervention in Preschool Children With FASDActive, not recruitingNCT01536184
25Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of TechnologyEnrolling by invitationNCT02759874
26Prenatal Alcohol Biomarker Study in UruguayNot yet recruitingNCT02600624
27Better Nights, Better Days for Children With Neurodevelopment DisordersNot yet recruitingNCT02694003
28Modeling and Testing Change in Mental Abilities in ChildhoodNot yet recruitingNCT02459873
29Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)TerminatedNCT00747630Phase 0

Search NIH Clinical Center for Fetal Alcohol Syndrome

Genetic Tests for Fetal Alcohol Syndrome

About this section

Anatomical Context for Fetal Alcohol Syndrome

About this section

MalaCards organs/tissues related to Fetal Alcohol Syndrome:

33
Breast, Eye, Placenta, Testes, Skin, T cells, Brain

Animal Models for Fetal Alcohol Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Fetal Alcohol Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053867.1ADH7, CHRM3, GFAP, GRIN2A, GRIN2B, L1CAM
2MP:00053786.7ADH7, AKR1A1, CHRM3, GFAP, GRIN2B, KCNJ2
3MP:00036316.1ADH7, ADNP, CHRM3, GFAP, GRIN2A, GRIN2B

Publications for Fetal Alcohol Syndrome

About this section

Articles related to Fetal Alcohol Syndrome:

(show top 50)    (show all 526)
idTitleAuthorsYear
1
Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC. (25569455)
2015
2
Case report: drug-induced gingival overgrowth associated with the use of a calcium channel blocker (amlodipine). (26665904)
2015
3
Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. (24812271)
2014
4
Clubbing, cyanosis and a new diagnosis of atrial septal defect in a parturient: a straightforward diagnosis of Eisenmenger syndrome? (23329721)
2013
5
Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus. (23839909)
2013
6
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms. (23271221)
2013
7
A case of myasthenia gravis presenting solely with bulbar palsy unassociated with easy fatigability. (23524604)
2013
8
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. (22875613)
2013
9
Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. (22460731)
2012
10
Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. (22144890)
2011
11
The premenstrual tension syndrome rating scales: an updated version. (21802738)
2011
12
Dynamic regulation of fibrinogen: integrin I+IIbI^3 binding. (20828133)
2010
13
Reducing intraoperative bleeding of juvenile nasopharyngeal angiofibroma. (21492601)
2010
14
Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma. (19787833)
2009
15
Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk. (19618370)
2009
16
Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001). (19424940)
2009
17
Bronchiectasis, part 2: Management. (20046814)
2008
18
Septic arthritis: current diagnostic and therapeutic algorithm. (18525361)
2008
19
Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients. (17584019)
2007
20
Phylogenetic comparison of protein-coding versus ribosomal RNA-coding sequence data: a case study of the Lecanoromycetes (Ascomycota). (17207641)
2007
21
Detection of Molluscum contagiosum virus (MCV) subtype I as a single dominant virus subtype in Molluscum lesions from a Turkish population. (16513490)
2006
22
The neural cell adhesion molecule NCAM regulates neuritogenesis by multiple mechanisms of interaction. (16469417)
2006
23
PRIP, a novel Ins(1,4,5)P3 binding protein, functional significance in Ca2+ signaling and extension to neuroscience and beyond. (16404143)
2005
24
Microsatellite marker analysis as a typing system for Candida glabrata. (16145109)
2005
25
A new LMNA mutation causing limb girdle muscular dystrophy 1B. (15789136)
2005
26
Continual expression of Rab5(Q79L) causes a ligand-independent EGFR internalization and diminishes EGFR activity. (15260830)
2004
27
Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. (15254225)
2004
28
Beneficial effects of raloxifene and atorvastatin on serum lipids and HDL phospholipids levels of postmenopausal women. (15203583)
2004
29
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. (12548559)
2003
30
Angiotensinogen genotype, plasma protein and mRNA concentration in isolated systolic hypertension. (12081721)
2002
31
Study of the fluoridated adhesive resin cement--fluoride release, fluoride uptake and acid resistance of tooth structures. (11441484)
2001
32
Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. (10607769)
2000
33
Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism. (11055650)
2000
34
Transcytosis and coenzymatic conversion of [(57)Co]cobalamin bound to either endogenous transcobalamin II or exogenous intrinsic factor in caco-2 cells. (10878444)
2000
35
Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil. (11197059)
2000
36
Assessment of quality of life in children with rheumatic disease. (10405925)
1999
37
Noonan syndrome presented with cystic hygroma and chylothorax: case report. (10493040)
1999
38
Plasma gelsolin is reduced in trauma patients. (10446889)
1999
39
Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma. (9893642)
1998
40
Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis. (9347503)
1997
41
Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. (9181649)
1997
42
Mouse Zp1 encodes a zona pellucida protein homologous to egg envelope proteins in mammals and fish. (7592984)
1995
43
Female pseudohermaphroditism with multiple caudal anomalies: absence of Y-specific DNA sequences as pathogenetic factors. (7913293)
1994
44
Increasing progesterone secretion and 3 beta-hydroxysteroid dehydrogenase activity of human cumulus cells and granulosa-lutein cells concurrent with successful fertilization of the corresponding oocyte. (7826892)
1994
45
Antidiabetic sulfonylureas antagonize somatostatin inhibition of prolactin secretion in vitro. (1358652)
1992
46
Iron status in runners of various running specialties. (1692684)
1990
47
Effect of the resin system on dentin bond strength]. (2114258)
1990
48
The human hypophysis in anencephaly. I. Ultrastructure of the pars distalis. (5763625)
1969
49
Bullous Purpura following Impetigo. (19973963)
1909
50

Variations for Fetal Alcohol Syndrome

About this section

Expression for genes affiliated with Fetal Alcohol Syndrome

About this section
Search GEO for disease gene expression data for Fetal Alcohol Syndrome.

Pathways for genes affiliated with Fetal Alcohol Syndrome

About this section

GO Terms for genes affiliated with Fetal Alcohol Syndrome

About this section

Cellular components related to Fetal Alcohol Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1NMDA selective glutamate receptor complexGO:001714610.0GRIN2A, GRIN2B
2neuronal cell bodyGO:00430259.6KCNJ2, PVALB, VIP

Biological processes related to Fetal Alcohol Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1regulation of sensory perception of painGO:005193010.1GRIN2A, VIP
2learning or memoryGO:00076119.9GRIN2A, VIP
3transportGO:00068109.3GRIN2A, GRIN2B, RBP1
4oxidation-reduction processGO:00551149.0ADH1B, ADH7, AKR1A1

Molecular functions related to Fetal Alcohol Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1retinol bindingGO:00198419.2ADH7, RBP1

Sources for Fetal Alcohol Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet